Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.765 USD | +3.15% | +8.48% | -12.62% |
Financials (USD)
Sales 2024 * | 104M | Sales 2025 * | 119M | Capitalization | 191M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 1.84 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.61 x |
P/E ratio 2024 * |
-365
x | P/E ratio 2025 * |
17.8
x | Employees | 157 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.84% |
Latest transcript on Alimera Sciences, Inc.
1 day | -0.96% | ||
1 week | +5.49% | ||
Current month | -0.82% | ||
1 month | -3.44% | ||
3 months | -6.17% | ||
6 months | +7.35% | ||
Current year | -15.51% |
Managers | Title | Age | Since |
---|---|---|---|
David Holland
FOU | Founder | 60 | 03-06-03 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Pizzo
BRD | Director/Board Member | 57 | 10-03-31 |
Richard Eiswirth
CEO | Chief Executive Officer | 55 | 05-09-30 |
Charles Myers
FOU | Founder | 70 | 03-06-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 3.765 | +3.15% | 6 341 |
24-05-08 | 3.65 | +2.24% | 35,796 |
24-05-07 | 3.57 | -4.80% | 57,870 |
24-05-06 | 3.75 | +2.74% | 99,562 |
24-05-03 | 3.65 | +4.89% | 143,580 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.51% | 191M | |
-3.35% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+51.08% | 24.73B | |
-15.13% | 15.54B | |
-40.39% | 12.07B | |
-8.63% | 12.05B | |
-14.78% | 12.02B | |
+6.22% | 8.84B |
- Stock Market
- Equities
- ALIM Stock